The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer
Recent studies have demonstrated the prognostic value of the C-reactive protein/albumin (CRP/Alb) ratio in cancer. However, the role of the CRP/Alb ratio in advanced pancreatic cancer (PC) has not been examined. A retrospective study of 233 patients with advanced PC was conducted. We investigated th...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer Netherlands
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080377/ |